市場調査レポート

商品コード

前臨床CROの世界市場 2025～2029年

Global Preclinical CRO Market 2025-2029

出版日: 2025年01月31日
発行: TechNavio
ページ情報: 英文 190 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 367,475円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 587,960円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.99円

全表示
概要
目次

概要

サンプル依頼リストに入れる

前臨床CRO市場は、2024～2029年にかけて27億3,480万米ドル、予測期間中のCAGRは8.1％で成長すると予測されています。

当レポートでは、前臨床CRO市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、医療インフラにおける技術と進歩の増加、前臨床CROに関連する非中核機能のアウトソーシングの成長によって牽引されています。

市場範囲
基準年	2025年
終了年	2029年
予測期間	2025～2029年
成長モメンタム	加速
前年比[2025年]	7.6%
CAGR	8.1%
増分額	27億3,480万米ドル

本調査は、産業の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間における前臨床CRO市場の成長を促進する主要要因の一つとして、臨床検査数の増加を挙げています。また、医薬品開発のための研究開発予算の増加、新薬や治療に対する需要の増加は、市場の大きな需要につながります。

地域別セグメンテーション
比較：地域別
北米：市場規模と予測 2024～2029年
欧州：市場規模と予測 2024～2029年
アジア：市場規模と予測 2024～2029年
その他：市場規模と予測 2024～2029年
米国：市場規模と予測 2024～2029年
ドイツ：市場規模と予測 2024～2029年
英国：市場規模と予測 2024～2029年
カナダ：市場規模と予測 2024～2029年
中国：市場規模と予測 2024～2029年
インド：市場規模と予測 2024～2029年
フランス：市場規模と予測 2024～2029年
日本：市場規模と予測 2024～2029年
メキシコ：市場規模と予測 2024～2029年
イタリア：市場規模と予測 2024～2029年
地域情勢による市場機会

第12章促進要因・課題・機会・抑制要因

市場促進要因
市場課題
促進要因と課題の影響
市場機会・抑制要因

第13章競合情勢

概要
競合情勢
混乱の状況
産業のリスク

第14章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
Altasciences
AmplifyBio
Charles River Laboratories International Inc.
Crown Bioscience
Eurofins Scientific SE
ICON plc
Imavita S.A.S.
IQVIA Holdings Inc.
Kunming Biomed International Ltd.
Laboratory Corp. of America Holdings
Medpace Holdings Inc.
PPD
Veeda Clinical Research Ltd.
Vivotecnia
WuXi AppTec Co. Ltd.

第15章付録

Product Code: IRTNTR75727

The preclinical CRO market is forecasted to grow by USD 2734.8 million during 2024-2029, accelerating at a CAGR of 8.1% during the forecast period. The report on the preclinical CRO market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, increase in technology and advancements in healthcare infrastructure, and growth in outsourcing of non-core functions related to preclinical CRO.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	7.6%
CAGR	8.1%
Incremental Value	$2734.8 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's preclinical CRO market is segmented as below:

By End-user

P and B companies
Medical device companies
Academic institutes

By Service

Toxicology testing
Bioanalysis and DMPK studies
Compound management
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing number of clinical trials as one of the prime reasons driving the preclinical CRO market growth during the next few years. Also, rise in research and development budget for drug development and increasing demand for new drugs and medical treatments will lead to sizable demand in the market.

The report on the preclinical CRO market covers the following areas:

Preclinical CRO Market sizing
Preclinical CRO Market forecast
Preclinical CRO Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical CRO market vendors that include Altasciences, AmplifyBio, BioEmission Technology Solutions, Charles River Laboratories International Inc., Crown Bioscience, CYNBIOSE, Eurofins Scientific SE, Gempharmatech Co. Ltd., Global Center for Medical Innovation, ICON PLC, Imavita S.A.S., IQVIA Holdings Inc., Kunming Biomed International Ltd., Laboratory Corp. of America Holdings, Medpace Holdings Inc., Parexel International Corp., PPD, Veeda Clinical Research Ltd., Vivotecnia, and WuXi AppTec Co. Ltd.. Also, the preclinical CRO market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Service
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Preclinical CRO Market 2019 - 2023
- Historic Market Size - Data Table on Global Preclinical CRO Market 2019 - 2023 ($ million)
5.2 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.3 Service segment analysis 2019 - 2023
- Historic Market Size - Service Segment 2019 - 2023 ($ million)
5.4 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.5 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The AI impact on Global Preclinical CRO Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by End-user

8.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
8.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
8.3 P and B companies - Market size and forecast 2024-2029
- Chart on P and B companies - Market size and forecast 2024-2029 ($ million)
- Data Table on P and B companies - Market size and forecast 2024-2029 ($ million)
- Chart on P and B companies - Year-over-year growth 2024-2029 (%)
- Data Table on P and B companies - Year-over-year growth 2024-2029 (%)
8.4 Medical device companies - Market size and forecast 2024-2029
- Chart on Medical device companies - Market size and forecast 2024-2029 ($ million)
- Data Table on Medical device companies - Market size and forecast 2024-2029 ($ million)
- Chart on Medical device companies - Year-over-year growth 2024-2029 (%)
- Data Table on Medical device companies - Year-over-year growth 2024-2029 (%)
8.5 Academic institutes - Market size and forecast 2024-2029
- Chart on Academic institutes - Market size and forecast 2024-2029 ($ million)
- Data Table on Academic institutes - Market size and forecast 2024-2029 ($ million)
- Chart on Academic institutes - Year-over-year growth 2024-2029 (%)
- Data Table on Academic institutes - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

9 Market Segmentation by Service

9.1 Market segments
- Chart on Service - Market share 2024-2029 (%)
- Data Table on Service - Market share 2024-2029 (%)
9.2 Comparison by Service
- Chart on Comparison by Service
- Data Table on Comparison by Service
9.3 Toxicology testing - Market size and forecast 2024-2029
- Chart on Toxicology testing - Market size and forecast 2024-2029 ($ million)
- Data Table on Toxicology testing - Market size and forecast 2024-2029 ($ million)
- Chart on Toxicology testing - Year-over-year growth 2024-2029 (%)
- Data Table on Toxicology testing - Year-over-year growth 2024-2029 (%)
9.4 Bioanalysis and DMPK studies - Market size and forecast 2024-2029
- Chart on Bioanalysis and DMPK studies - Market size and forecast 2024-2029 ($ million)
- Data Table on Bioanalysis and DMPK studies - Market size and forecast 2024-2029 ($ million)
- Chart on Bioanalysis and DMPK studies - Year-over-year growth 2024-2029 (%)
- Data Table on Bioanalysis and DMPK studies - Year-over-year growth 2024-2029 (%)
9.5 Compound management - Market size and forecast 2024-2029
- Chart on Compound management - Market size and forecast 2024-2029 ($ million)
- Data Table on Compound management - Market size and forecast 2024-2029 ($ million)
- Chart on Compound management - Year-over-year growth 2024-2029 (%)
- Data Table on Compound management - Year-over-year growth 2024-2029 (%)
9.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Service
- Market opportunity by Service ($ million)
- Data Table on Market opportunity by Service ($ million)

10 Customer Landscape

10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

11 Geographic Landscape

11.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
11.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
11.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
11.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
11.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
11.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
11.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
11.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
11.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
11.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
11.12 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
11.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
11.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
11.15 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
11.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
11.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

12 Drivers, Challenges, and Opportunity/Restraints

12.1 Market drivers
12.2 Market challenges
12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
12.4 Market opportunities/restraints

13 Competitive Landscape

13.1 Overview
13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
- Overview on factors of disruption
13.4 Industry risks
- Impact of key risks on business

14 Competitive Analysis

14.1 Companies profiled
- Companies covered
14.2 Company ranking index
- Company ranking index
14.3 Market positioning of companies
- Matrix on companies position and classification
14.4 Altasciences
- Altasciences - Overview
- Altasciences - Product / Service
- Altasciences - Key offerings
- SWOT
14.5 AmplifyBio
- AmplifyBio - Overview
- AmplifyBio - Product / Service
- AmplifyBio - Key offerings
- SWOT
14.6 Charles River Laboratories International Inc.
- Charles River Laboratories International Inc. - Overview
- Charles River Laboratories International Inc. - Business segments
- Charles River Laboratories International Inc. - Key offerings
- Charles River Laboratories International Inc. - Segment focus
- SWOT
14.7 Crown Bioscience
- Crown Bioscience - Overview
- Crown Bioscience - Product / Service
- Crown Bioscience - Key offerings
- SWOT
14.8 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key news
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
14.9 ICON plc
- ICON plc - Overview
- ICON plc - Product / Service
- ICON plc - Key offerings
- SWOT
14.10 Imavita S.A.S.
- Imavita S.A.S. - Overview
- Imavita S.A.S. - Product / Service
- Imavita S.A.S. - Key offerings
- SWOT
14.11 IQVIA Holdings Inc.
- IQVIA Holdings Inc. - Overview
- IQVIA Holdings Inc. - Business segments
- IQVIA Holdings Inc. - Key news
- IQVIA Holdings Inc. - Key offerings
- IQVIA Holdings Inc. - Segment focus
- SWOT
14.12 Kunming Biomed International Ltd.
- Kunming Biomed International Ltd. - Overview
- Kunming Biomed International Ltd. - Product / Service
- Kunming Biomed International Ltd. - Key offerings
- SWOT
14.13 Laboratory Corp. of America Holdings
- Laboratory Corp. of America Holdings - Overview
- Laboratory Corp. of America Holdings - Business segments
- Laboratory Corp. of America Holdings - Key news
- Laboratory Corp. of America Holdings - Key offerings
- Laboratory Corp. of America Holdings - Segment focus
- SWOT
14.14 Medpace Holdings Inc.
- Medpace Holdings Inc. - Overview
- Medpace Holdings Inc. - Product / Service
- Medpace Holdings Inc. - Key offerings
- SWOT
14.15 PPD
- PPD - Overview
- PPD - Product / Service
- PPD - Key offerings
- SWOT
14.16 Veeda Clinical Research Ltd.
- Veeda Clinical Research Ltd. - Overview
- Veeda Clinical Research Ltd. - Product / Service
- Veeda Clinical Research Ltd. - Key offerings
- SWOT
14.17 Vivotecnia
- Vivotecnia - Overview
- Vivotecnia - Product / Service
- Vivotecnia - Key offerings
- SWOT
14.18 WuXi AppTec Co. Ltd.
- WuXi AppTec Co. Ltd. - Overview
- WuXi AppTec Co. Ltd. - Business segments
- WuXi AppTec Co. Ltd. - Key offerings
- WuXi AppTec Co. Ltd. - Segment focus
- SWOT

15 Appendix

15.1 Scope of the report
15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
15.3 Currency conversion rates for US$
- Currency conversion rates for US$
15.4 Research methodology
- Research methodology
15.5 Data procurement
- Information sources
15.6 Data validation
- Data validation
15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
15.8 Data synthesis
- Data synthesis
15.9 360 degree market analysis
- 360 degree market analysis
15.10 List of abbreviations
- List of abbreviations

前臨床CROの世界市場 2025～2029年

Global Preclinical CRO Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：エンドユーザー別

第9章市場セグメンテーション：サービス別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by End-user

9 Market Segmentation by Service

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

前臨床CROの世界市場 2025～2029年

Global Preclinical CRO Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：エンドユーザー別

第9章 市場セグメンテーション：サービス別

第10章 顧客情勢

第11章 地域別情勢

第12章 促進要因・課題・機会・抑制要因

第13章 競合情勢

第14章 競合分析

第15章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by End-user

9 Market Segmentation by Service

10 Customer Landscape

11 Geographic Landscape

12 Drivers, Challenges, and Opportunity/Restraints

13 Competitive Landscape

14 Competitive Analysis

15 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：エンドユーザー別

第9章市場セグメンテーション：サービス別

第10章顧客情勢

第11章地域別情勢

第12章促進要因・課題・機会・抑制要因

第13章競合情勢

第14章競合分析

第15章付録